Atrial fibrillation and chronic kidney disease - Clinical and therapeutic interactions
DOI:
https://doi.org/10.33448/rsd-v14i2.48213Keywords:
Atrial Fibrilation; Kidney Disease, Chronic; Propaedeutics.Abstract
Introduction: The clinical and therapeutic interactions between atrial fibrillation and chronic kidney disease have become a relevant object of study in the medical context, given the high incidence of the diseases coexisting in the same patient. Objective: The aim of this study was to characterize the clinical and therapeutic interactions between atrial fibrillation and chronic kidney disease, building on robust literature reviews. Materials and Methods: This is an integrative literature review on the congruences between clinical and therapeutic aspects of atrial fibrillation and chronic kidney disease. The PICO strategy was used to develop the guiding question. In addition, the descriptors “Atrial Fibrillation”; “Chronic Kidney Disease”; “Propaedeutics” were cross-referenced in the National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (SCIELO), Ebscohost, Google Scholar and Virtual Health Library (VHL) databases. Results and Discussion: The studies showed that there is a bidirectionality in the clinical and therapeutic interactions between atrial fibrillation and chronic kidney disease. In this sense, the mechanisms of cardiac structural remodeling and systemic inflammation stand out as the cause of this coexistence and cause-effect, resulting in clinical manifestations and the need for new propaedeutics Conclusion: It is necessary to consider the degree of renal dysfunction when establishing the treatment of atrial fibrillation in patients with chronic kidney disease, in order to avoid an increase in complications and cardiovascular risk.
References
Ajam, F., Patel, S., Alrefaee, A., Calderon, D., Hossain, M. A., & Asif, A. (2019). Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief. American Journal of Internal Medicine, 7(1), 22-26.
Amdur, R. L., Mukherjee, M., Go, A., Barrows, I. R., Ramezani, A., Shoji, J., & CRIC Study Investigators. (2016). Interleukin-6 is a risk factor for atrial fibrillation in chronic kidney disease: findings from the CRIC study. PLoS One, 11(2), e0148189.
Armaganijan, D., Armaganijan, L. V., & Staico, R. (2017). Terapias anticoagulantes na doença renal crônica. Rev. Soc. Cardiol. Estado de Säo Paulo, 238-242.
Bansal, N., Fan, D., Hsu, C. Y., Ordonez, J. D., & Go, A. S. (2014). Incident atrial fibrillation and risk of death in adults with chronic kidney disease. Journal of the American Heart Association, 3(5), e001303.
Bansal, N., Xie, D., Tao, K., Chen, J., Deo, R., Horwitz, E., & Go, A. S. (2016). Atrial fibrillation and risk of ESRD in adults with CKD. Clinical Journal of the American Society of Nephrology, 11(7), 1189-1196.
Carvalho, A. P. V. (2021). Rastreio de fibrilação atrial subclínica entre os pacientes portadores de doença renal crônica dialítica usando um novo dispositivo portátil (Dissertação de Mestrado). Universidade Federal de Minas Gerais, Belo Horizonte, MG.
Jun, M., James, M. T., Manns, B. J., Quinn, R. R., Ravani, P., Tonelli, M., & Hemmelgarn, B. R. (2015). The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study. BMJ, 350.
Kiuchi, M. G., & Mion Jr, D. (2016). Doença renal crônica e fatores de risco para morte súbita cardíaca-denervaçao renal simpática: um sopro de esperança? Doença renal crônica e fatores de risco para morte súbita cardíaca-denervaçao renal simpática: um sopro de esperança?. Journal of Cardiac Arrhythmias, 29(3), 108-119.
Kumar, S., Lim, E., Covic, A., Verhamme, P., Gale, C. P., Camm, A. J., & Goldsmith, D. (2019). Anticoagulation in concomitant chronic kidney disease and atrial fibrillation: JACC review topic of the week. Journal of the American College of Cardiology, 74(17), 2204-2215.
Lullo, L., House, A., Gorini, A., Santoboni, A., Russo, D., & Ronco, C. (2015). Chronic kidney disease and cardiovascular complications. Heart failure reviews, 20, 259-272.
Odutayo, A., Wong, C. X., Hsiao, A. J., Hopewell, S., Altman, D. G., & Emdin, C. A. (2016). Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ, 354.
Oliveira, L. V. P., Bernardes, C. F., Ribeiro, I. R. F., & de Oliveira Santos, P. R. (2024). Uso de anticoagulantes em pacientes com fibrilação atrial: uma revisão sistemática. RCMOS-Revista Científica Multidisciplinar O Saber, 1(1).
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. UFSM.
Pinto, C. E. R., Bueno, E. T., Pires, T. S. C. F., Brito, B. S., de Castro, P. V. I. P., & Reis, B. C. C. (2020). Uso de Novos Anticoagulantes em pacientes com Fibrilação Atrial. Revista de Saúde, 11(2), 20-24.
Potpara, T. S., Ferro, C. J., & Lip, G. Y. (2018). Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction. Nature Reviews Nephrology, 14(5), 337-351.
Priori, S. L. (2020). Alterações eletrocardiográficas preditoras de fibrilação atrial (FA) em pacientes com doença renal crônica no primeiro ano de hemodiálise (Dissertação de Mestrado). Universidade de São Paulo, São Paulo, SP.
Silva, L. A. A., Filho, I. B. T., & Júnior, E. F. X. (2020). Anticoagulação Oral em Pacientes Portadores de Fibrilação Atrial Não Valvar de Alto Risco. Revista Norte Nordeste de Cardiologia, 10(2), 2-10.
Soliman, E. Z., Prineas, R. J., Go, A. S., Xie, D., Lash, J. P., Rahman, M., ... & Chronic Renal Insufficiency Cohort (CRIC) Study Group. (2010). Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). American heart journal, 159(6), 1102-1107.
Souza, M. T. D., Silva, M. D. D., & Carvalho, R. D. (2010). Revisão integrativa: o que é e como fazer. Einstein (São Paulo), 8, 102-106.
Suwanwongse, K., & Shabarek, N. (2020). Does atrial fibrillation increase the risk of developing end-stage renal disease in patients with chronic kidney disease?. Cureus, 12(2).
Teixeira, J. H. A., do Nascimento, J. V. R., de Oliveira, M. P. D. V., & Beraldo, P. H. B. (2024). Uso de anticoagulantes orais em pacientes com fibrilação atrial e doença renal crônica. Revista Ibero-Americana de Humanidades, Ciências e Educação, 10(9), 2579-2589.
Turakhia, M. P., Blankestijn, P. J., Carrero, J. J., Clase, C. M., Deo, R., Herzog, C. A., & Wanner, C. (2018). Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. European heart journal, 39(24), 2314-2325.
Xu, D., Murakoshi, N., Sairenchi, T., Irie, F., Igarashi, M., Nogami, A., & Aonuma, K. (2015). Anemia and reduced kidney function as risk factors for new onset of atrial fibrillation (from the Ibaraki prefectural health study). The American journal of cardiology, 115(3), 328-333.
Yao, X., Tangri, N., Gersh, B. J., Sangaralingham, L. R., Shah, N. D., Nath, K. A., & Noseworthy, P. A. (2017). Renal outcomes in anticoagulated patients with atrial fibrillation. Journal of the American College of Cardiology, 70(21), 2621-2632.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Alice Gerdullo Pin; Caroline Guimarães Dantas de Siqueira; Mateus Borges Santos Mendes; Márcio Magela Godoi Moreira Filho; Lucas Lopes Barbosa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
